X-108164992-C-T

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_033641.4(COL4A6):​c.3855G>A​(p.Ser1285Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00569 in 1,208,093 control chromosomes in the GnomAD database, including 237 homozygotes. There are 1,761 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.029 ( 114 hom., 787 hem., cov: 23)
Exomes 𝑓: 0.0033 ( 123 hom. 974 hem. )

Consequence

COL4A6
NM_033641.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -2.59
Variant links:
Genes affected
COL4A6 (HGNC:2208): (collagen type IV alpha 6 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene, alpha 5 type IV collagen, so that the gene pair shares a common promoter. Deletions in the alpha 5 gene that extend into the alpha 6 gene result in diffuse leiomyomatosis accompanying the X-linked Alport syndrome caused by the deletion in the alpha 5 gene. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant X-108164992-C-T is Benign according to our data. Variant chrX-108164992-C-T is described in ClinVar as [Benign]. Clinvar id is 258277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.59 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0982 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A6NM_033641.4 linkc.3855G>A p.Ser1285Ser synonymous_variant Exon 39 of 45 ENST00000334504.12 NP_378667.1 Q14031-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A6ENST00000334504.12 linkc.3855G>A p.Ser1285Ser synonymous_variant Exon 39 of 45 5 NM_033641.4 ENSP00000334733.7 Q14031-2

Frequencies

GnomAD3 genomes
AF:
0.0291
AC:
3214
AN:
110286
Hom.:
114
Cov.:
23
AF XY:
0.0238
AC XY:
777
AN XY:
32610
show subpopulations
Gnomad AFR
AF:
0.101
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0114
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000404
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000418
Gnomad OTH
AF:
0.0200
GnomAD3 exomes
AF:
0.00910
AC:
1654
AN:
181742
Hom.:
57
AF XY:
0.00606
AC XY:
404
AN XY:
66656
show subpopulations
Gnomad AFR exome
AF:
0.111
Gnomad AMR exome
AF:
0.00612
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000420
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000247
Gnomad OTH exome
AF:
0.00423
GnomAD4 exome
AF:
0.00333
AC:
3652
AN:
1097749
Hom.:
123
Cov.:
31
AF XY:
0.00268
AC XY:
974
AN XY:
363165
show subpopulations
Gnomad4 AFR exome
AF:
0.110
Gnomad4 AMR exome
AF:
0.00706
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000296
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000164
Gnomad4 OTH exome
AF:
0.00725
GnomAD4 genome
AF:
0.0292
AC:
3227
AN:
110344
Hom.:
114
Cov.:
23
AF XY:
0.0241
AC XY:
787
AN XY:
32678
show subpopulations
Gnomad4 AFR
AF:
0.101
Gnomad4 AMR
AF:
0.0114
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000404
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000419
Gnomad4 OTH
AF:
0.0198
Alfa
AF:
0.0159
Hom.:
80
Bravo
AF:
0.0350
EpiCase
AF:
0.000600
EpiControl
AF:
0.000415

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

May 23, 2018
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 08, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Hearing loss, X-linked 6 Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
0.80
DANN
Benign
0.65

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34132805; hg19: chrX-107408222; COSMIC: COSV104638718; COSMIC: COSV104638718; API